157547-47-2

Basic information

• Product Name: 3-(2'-Hydroxy-5'-benzyloxy-4',6'-dimethylphenyl)-3,3-dimethyl-1-propanol
• Synonyms: 3-(2'-Hydroxy-5'-benzyloxy-4',6'-dimethylphenyl)-3,3-dimethyl-1-propanol
• CAS NO: 157547-47-2
• Molecular Weight: 314.425
• Mol File: 157547-47-2.mol

Chemical Properties

• CAS DataBase Reference: 3-(2'-Hydroxy-5'-benzyloxy-4',6'-dimethylphenyl)-3,3-dimethyl-1-propanol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2'-Hydroxy-5'-benzyloxy-4',6'-dimethylphenyl)-3,3-dimethyl-1-propanol(157547-47-2)
• EPA Substance Registry System: 3-(2'-Hydroxy-5'-benzyloxy-4',6'-dimethylphenyl)-3,3-dimethyl-1-propanol(157547-47-2)

Safety Data

• Hazardous Substances Data: 157547-47-2(Hazardous Substances Data)

Upstream product

• 100-44-7 benzyl chloride 
• 50442-68-7 6-hydroxy-4,4,5,7-tetramethyl-3,4-dihydrocoumarin 
• 157547-46-1 6-benzyloxy-4,4,5,7-tetramethylhydrocoumarin 

Downstream Products

• 264888-45-1 phenyl-acetic acid 3-(3-benzyloxy-6-hydroxy-2,4-dimethyl-phenyl)-3-methyl-butyl ester 
• 264888-38-2 2-tert-butoxycarbonylamino-succinic acid 4-benzyl ester 1-[3-(3-benzyloxy-6-hydroxy-2,4-dimethyl-phenyl)-3-methyl-butyl] ester 
• 264888-40-6 3-benzyloxy-2-tert-butoxycarbonylamino-propionic acid 3-(3-benzyloxy-6-hydroxy-2,4-dimethyl-phenyl)-3-methyl-butyl ester 
• 264888-42-8 propionic acid 3-(3-benzyloxy-6-hydroxy-2,4-dimethyl-phenyl)-3-methyl-butyl ester 
• 264888-44-0 2,2-dimethyl-propionic acid 3-(3-benzyloxy-6-hydroxy-2,4-dimethyl-phenyl)-3-methyl-butyl ester 
• 264888-56-4 6-benzyloxycarbonylamino-2-tert-butoxycarbonylamino-hexanoic acid 3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyl ester 
• 264888-67-7 2-tert-butoxycarbonylamino-3-(1-formyl-1H-indol-3-yl)-propionic acid 3-(3,6-dihydroxy-2,4-dimethyl-phenyl)-3-methyl-butyl ester 
• 264888-52-0 2-tert-butoxycarbonylamino-3-(1-formyl-1H-indol-3-yl)-propionic acid 3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyl ester 
• 264888-53-1 2-tert-butoxycarbonylamino-succinic acid 4-benzyl ester 1-[3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyl] ester 
• 264888-54-2 3-benzylsulfanyl-2-tert-butoxycarbonylamino-propionic acid 3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyl ester 
• 264888-55-3 3-benzyloxy-2-tert-butoxycarbonylamino-propionic acid 3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyl ester 
• 264888-48-4 2-tert-butoxycarbonylamino-3-phenyl-propionic acid 3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyl ester 
• 264888-62-2 (S)-2-(6-Methoxy-naphthalen-2-yl)-propionic acid 3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyl ester 
• 264888-49-5 2-tert-butoxycarbonylamino-4-methyl-pentanoic acid 3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyl ester 

Relevant articles and documents

A facilitated cyclic ether formation and its potential application in solid-phase peptide and organic synthesis

A 'trimethyl lock' system has been known to facilitate lactonization reactions through what has been termed a stereopopulation control mechanism. We have found that a similar trimethyl lock system can also facilitate cyclic ether formation with the concom

Benzoate derivatives of taxol

This invention relates to a compound of formula I STR1 or a pharmaceutically acceptable salt thereof, in which R2 is a radical of the formula STR2 in which Ra and Rb are independently hydrogen or C1-6 alkyl, said C1-6 alkyl being optionally substituted with hydroxy, phosphono, phosphonooxy, carboxy or di(C1-6 alkyl) amino; or NRa Rb together represents a radical of the formula STR3 in which y is one to three, and Ra is as defined above; Rp and Rr are independently same or different C1-6 alkyl; R1 is hydrogen or a radical Z of the formula STR4 in which Q is --(CH2)f --, optionally substituted with one to six same or different C1-6 alkyl or C3-6 cycloalkyl, or a carbon atom of said --(CH2)f -- radical may also be a part of C3-6 cycloalkylidene; R3 and R4 are independently hydrogen or C1-6 alkyl, or R3 and R4 taken together with the carbon atom to which they are attached form C3-6 cycloalkylidene; R5 is --OC(=O)R, --OP=O(OH)2 or --CH2 OP=O(OH)2, in which R is C1-6 alkyl; R6, R7, R8 and R9 are independently halogen, C1-6 alkyl, C1-6 alkoxy or hydrogen, but when R5 is --OC(=O)R, one of R6, R7, R8 or R9 is --OP=O(OH)2 ; f is 2 to 6; n is O, and m is 1 or 0 when R5 is --CH2 OP=O(OH)2 ; and n is 1 or 0, and m is 1 when R5 is --OC(=O)R or --OP=O(OH)2. Also provided by this invention are pharmaceutical formulations and a method for treating mammalian tumors with a compound of formula I.

Phosphonooxy and carbonate derivatives of taxol

The present invention is directed to novel taxol derivatives useful as anti-tumor agents. Also provided by this invention is pharmaceutical formulations and methods of treating mammalian tumors with the compounds of this invention.